Retrovir AZT
Retrovir AZT is a medicine authorised by Swissmedic under authorisation number 51588. The authorisation holder is ViiV Healthcare GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 September 1993 and the authorisation is valid without a time limit. ATC code J05AF01 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 51588 |
|---|---|
| Name | Retrovir AZT |
| Full name | Retrovir AZT, Sirup |
| Authorisation holder | ViiV Healthcare GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AF01 |
| First authorisation | 13 September 1993 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Retrovir AZT, Sirup | A | 13 September 1993 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 200 | ml | J05AF01 | 08.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Retrovir AZT authorised in Switzerland?
Yes. Retrovir AZT is authorised by Swissmedic under authorisation number 51588, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Retrovir AZT have?
Retrovir AZT is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Retrovir AZT?
The authorisation holder is ViiV Healthcare GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.